Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity
NCT00460655
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
120
Enrollment
INDUSTRY
Sponsor class
Conditions
Post-Stroke Spasticity
Cerebrovascular Accident
Interventions
DRUG:
GSK1358820
DRUG:
Placebo
Sponsor
GlaxoSmithKline